Group 1 - The core viewpoint of the news is the performance and holdings of the Guangfa Healthcare Stock A fund, which has shown positive growth in recent months and year-to-date [1] - As of June 3, 2025, the net value of Guangfa Healthcare Stock A is 1.9017 yuan, with a growth of 1.33% [1] - The fund's performance over the past month is a return of 6.26%, ranking 115 out of 1025 in its category; over the past three months, it has returned 14.24%, ranking 59 out of 1009; and year-to-date, it has returned 17.65%, ranking 85 out of 999 [1] Group 2 - The top ten holdings of Guangfa Healthcare Stock A account for a total of 48.15%, with the largest holding being Zai Lab Ltd. at 10.52% [1] - Other significant holdings include Kelun Pharmaceutical (8.39%), Baillie Gifford (5.88%), and Hengrui Medicine (5.17%) [1] - The fund was established on August 10, 2017, and as of March 31, 2025, it has a total scale of 5.237 billion yuan, managed by fund manager Wu Xingwu [1]
6月3日广发医疗保健股票A净值增长1.33%，今年来累计上涨17.65%
Sou Hu Cai Jing·2025-06-03 13:40